VIE/CVS (VIE/CVS)

Vienna Stock Exchange: VIE/CVS · EUR

€81.3

-1.02 (-1.2%)· Recorded snapshot

Market cap	103.2B
Revenue (ttm)	361.2B
Net income (ttm)	4.3B
EPS (ttm)	€3.43
P/E (trailing)	23.7x
P/E (forward)	11.0x
Dividend	€2.31 (2.84%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 361.2B
Net income (ttm): 4.3B
EPS (ttm): €3.43
P/E (trailing): 23.7x
P/E (forward): 11.0x
Market cap: 103.2B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E11

P25 n/aP50 n/aP75 n/a

Trailing P/E23.7

P25 n/aP50 n/aP75 n/a

ROE6.2

P25 n/aP50 n/aP75 n/a

ROIC7.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All VIE/CVS indicators

Market & fundamental data

Available fields

245

Groups with data

Currency

USD

Showing 245 of 245 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	AT
Earnings date	2026-11-04
Employees	259,500
Employees change	0
Employees growth	0%
Enterprise value	EUR 159.3B
Exchange	Vienna Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1963
Industry	Healthcare Plans
Is primary listing	No
ISIN number	US1266501006
Last earnings date	2026-08-05
Last refreshed	2026-10-29
Market cap	EUR 103.2B
Next earnings date	2026-11-04
Price	EUR 81.32
Price currency	EUR
Sector	Healthcare
SIC code	8000
Stock price date	2026-10-28
Symbol	vie/CVS
Website	https://www.cvshealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	23.26x
Average P/E ratio (3Y)	35.75x
Average P/E ratio (5Y)	30.59x
Earnings yield	4.22%
EV/Earnings	37.23x
EV/EBIT	14.61x
EV/EBITDA	9.02x
EV/FCF	15.48x
EV/Sales	0.43x
FCF / EV yield	6.46%
FCF yield	9.97%
Forward P/E	10.97x
Graham number	64.65762
Graham upside	-20.49%
Lynch fair value	EUR 16.86
Lynch upside	-79.27%
P/(FCF - SBC) ratio	10.68x
P/(OCF - SBC) ratio	8.38x
P/B ratio	1.48x
P/E ratio	23.71x
P/FCF ratio	10.03x
P/OCF ratio	7.98x
P/S ratio	0.29x
Price/EBITDA ratio	7.07x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	2.95%
EBITDA margin	4.04%
Effective tax rate	15.59%
FCF margin	2.78%
Gross margin	13.64%
Operating margin	2.95%
Pretax margin	1.4%
Profit margin	1.19%
Profit per employee	EUR 16,494
Profitable quarters	3
Profitable years	7
Revenue per employee	EUR 1.4M
ROA	2.97%
ROA (5Y)	3.25%
ROCE	7.29%
ROE	6.21%
ROE (5Y)	7.3%
ROIC	7.17%
ROIC (5Y)	6.76%
SBC / revenue	0.17%
Tax / revenue	0.22%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	6.3%
EPS growth (Q)	188.75%
EPS growth (QoQ)	0.43%
EPS growth 10Y	-1.29%
EPS growth 3Y	18.83%
EPS growth 5Y	-6.92%
EPS growth quarters	3
EPS growth years	0
FCF growth	145.98%
FCF growth (Q)	338.3%
FCF growth (QoQ)	66.29%
FCF growth 3Y	-12.7%
FCF growth 5Y	0.24%
Gross profit growth	10.11%
Gross profit growth (Q)	15.28%
Gross profit growth 3Y	1.97%
Gross profit growth 5Y	3.1%
Net income growth	7.92%
Net income growth (Q)	191.77%
Net income growth (QoQ)	1.22%
Net income growth 3Y	18.15%
Net income growth 5Y	-7.45%
Net income growth quarters	3
Net income growth years	0
OCF growth	95.3%
OCF growth (Q)	234.48%
OCF growth (QoQ)	49.33%
OCF growth 10Y	4.54%
OCF growth 3Y	-10.36%
OCF growth 5Y	0.83%
Operating income growth	30.17%
Operating income growth (Q)	47.59%
Operating income growth 3Y	-5.64%
Operating income growth 5Y	-1.43%
Revenue growth	7.37%
Revenue growth (Q)	7.14%
Revenue growth (QoQ)	5.61%
Revenue growth 10Y	9.49%
Revenue growth 3Y	6.87%
Revenue growth 5Y	8.28%
Revenue growth quarters	53
Revenue growth years	15

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -2.6B
Depreciation and amortization	EUR 4.1B
EBIT	EUR 10.6B
EBITDA	EUR 14.6B
EPS	EUR 3.43
Financing cash flow	EUR -7.4B
Free cash flow	EUR 10.3B
Free cash flow minus SBC	EUR 9.7B
Gross profit	EUR 49.3B
Income taxes	EUR 789.5M
Investing cash flow	EUR -6B
Net borrowing	EUR -4.7B
Net cash flow	EUR -427.1M
Net income	EUR 4.3B
Operating cash flow minus SBC	EUR 12.3B
Operating income	EUR 10.6B
Revenue	EUR 361.2B
Stock-based compensation	EUR 625.8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.43
Book value per share	EUR 54.59
Debt / EBITDA	3.87
Debt / equity	0.96
Debt / FCF	6.49
Goodwill	EUR 76.8B
Interest coverage	3.92
Long-term assets	EUR 154.4B
Long-term liabilities	EUR 74B
Net cash (debt)	EUR -54.6B
Net cash / market cap	-52.87%
Net debt / EBITDA	3.74
Net debt / equity	0.78
Net debt / FCF	5.3
Piotroski F-Score	7
Property, plant and equipment	EUR 24.8B
Shareholders' equity	EUR 69.9B
Tangible book value	EUR -26.6B
Tangible book value per share	EUR -20.83
Total assets	EUR 222.1B
Total cash	EUR 12.2B
Total debt	EUR 66.8B
Total liabilities	EUR 152.2B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.61
Current assets	EUR 67.7B
Current liabilities	EUR 78.2B
Current ratio	0.87
Inventory turnover	20.32
Net working capital	EUR -19.1B
Quick ratio	0.62
Working capital	EUR -10.2B
Working capital turnover	-23.91

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-1.19%
Dividend growth	-1.96%
Dividend growth (3Y)	1.26%
Dividend growth (5Y)	6.56%
Dividend growth years	0
Dividend payment date	2026-11-02
Dividend payment years	8
Dividend payout frequency	Quarterly
Dividend per share	EUR 2.31
Dividend yield	2.84%
Ex-dividend date	2026-10-22
Last dividend	EUR 0.59
Payout ratio	69.86%
Shareholder yield	1.66%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 80.41
1D price change	-1.24%
1M price change	5.69%
1M total return	6.44%
1W price change	-3.24%
1W total return	-2.55%
1Y price change	15.68%
1Y return CAGR	19.28%
1Y total return	19.26%
20-day SMA	EUR 79.59
200-day SMA	EUR 76.77
3M price change	-13.25%
3M total return	-12.63%
3Y price change	28.67%
3Y return CAGR	12.87%
3Y total return	43.81%
50-day SMA	EUR 80.08
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 96.22
52-week high date	2026-07-29
52-week low	EUR 59.87
52-week low date	2026-01-28
5Y price change	7.11%
5Y return CAGR	4.79%
5Y total return	26.34%
6M price change	22.43%
6M total return	24.07%
All-time high	EUR 104.68
All-time high date	2022-08-16
All-time low	EUR 41.88
All-time low date	2024-12-20
Average true range (ATR)	EUR 1.40
Average volume	0.2
Change from 52-week high	-15.49%
Change from 52-week low	35.83%
Change from all-time high	-22.32%
Change from all-time low	94.17%
Change from open	-0.51%
Day's gap	-0.73%
High price	EUR 81.74
Low price	EUR 81.32
Monthly RSI	57.69
Open price	EUR 81.74
Position in 52-week range	0%
Previous close	EUR 82.34
Price vs 150-day SMA	1.13%
Price vs 20-day SMA	2.17%
Price vs 200-day SMA	5.92%
Price vs 50-day SMA	1.55%
Relative volume	20
RSI	52.88
Sharpe ratio	0.62
Sharpe ratio (3Y)	0.33
Sharpe ratio (5Y)	0.21
Sortino ratio	1.1
Sortino ratio (3Y)	0.64
Sortino ratio (5Y)	0.47
Weekly RSI	51.77
YTD price change	19.38%
YTD total return	23.08%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.3B
Shares change (QoQ)	0.63%
Shares change (YoY)	1.19%
Shares held by insiders	0.09%
Shares held by institutions	90.43%
Short ratio	2 days

Deeper analysis on VIE/CVS

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/CVS report

Is a complete VIE/CVS research report available?

No complete published report is available for vie/CVS (VIE/CVS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/CVS (VIE/CVS)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/CVS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/CVS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/CVS

Frequently asked questions